Lymphoid neogenesis in chronic inflammatory diseases

Nature Reviews Immunology

Volumn 6, Issue 3, 2006, Pages 205-217

  Aloisi, Francesca ^a   Pujol Borrell, Ricardo ^b,c,d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Lirad   (Spain)

^c Germans Trias i Pujol   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM MODULATING CYCLOPHILIN LIGAND INTERACTOR IMMUNOGLOBULIN FUSION PROTEIN; CHEMOKINE; HYBRID PROTEIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LYMPHOTOXIN BETA RECEPTOR IMMUNOGLOBULIN FUSION PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RITUXIMAB; TRANSMEMBRANE ACTIVATOR IMMUNOGLOBULIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BREAST CARCINOMA; CLINICAL TRIAL; COMPETENCE; CROHN DISEASE; CYTOKINE RELEASE; DISEASE COURSE; FIBROSING ALVEOLITIS; GASTRITIS; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS C; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INFECTION; INFLAMMATORY DISEASE; INSULITIS; LYME DISEASE; LYMPHOID ORGAN; LYMPHOID TISSUE; MEDICAL INFORMATION; MYASTHENIA GRAVIS; NEGATIVE FEEDBACK; NONHUMAN; ORGANOGENESIS; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSPLANTATION; ULCERATIVE COLITIS;

ANIMALS; CHEMOKINES; CHEMOKINES, CC; CHRONIC DISEASE; GERMINAL CENTER; HUMANS; IMMUNOTHERAPY; INFECTION; INFLAMMATION; LYMPHOID TISSUE;

EID: 33344475672     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1786     Document Type: Review

References (126)

1. Söderström, N. & Biörklund, A. Organization of the invading lymphoid tissue in human lymphoid thyroiditis. Scand. J. Immunol. 3, 295-301 (1974).
2. Levine, G. D. & Rosai, J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum. Pathol. 9, 495-515 (1978).
3. Prineas, J. W. Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 103, 1123-1125 (1979).
4. Knecht, H., Saremaslani, P. & Hedinger, C., Immunohistological findings in Hashimoto's thyroiditis, focal lymphocytic thyroiditis and thyroiditis de Quervain. Virchows Arch. 393, 251-231 (1981).
5. Thomas, J. A., Willcox, H. N. & Newsom-Davis, J. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses. J. Neuroimmunol. 3, 319-335 (1982).
6. Young, C. L. & Adamson, T. C., Vaughan, J. H., Fox, R. I. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum. 27, 32-39 (1984).
7. Ruddle, N. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19, 119-125 (1999).
8. Hjelmström, P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69, 331-339 (2001).
9. Ansel, K. M. & Cyster, J. G. Chemokines in lymphopoiesis and lymphoid organ development. Curr. Opin. Immunol. 13, 172-179 (2001).
10. Muller, G., Hopken, U. E. & Lipp, M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195, 117-135 (2003).
11. Mebius, R. E. Organogenesis of lymphoid tissues. Nature Rev. Immunol. 3, 292-303 (2003).
12. Nishikawa, S., Honda, K., Vieira, P. & Yoshida, H. Organogenesis of peripheral lymphoid organs. Immunol. Rev. 195, 72-80 (2003).
13. Cupedo, T. & Mebius, R. E. Role of chemokines in the development of secondary and tertiary lymphoid tissue. Semin. Immunol. 15, 243-248 (2003).
14. Magalhães, R., Stiehl, P., Morawietz, L. & Berek, C. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch. 441, 415-427 (2002).
15. Armengol, M. P. et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159, 861-873 (2001). This paper provides the first evidence of functionally competent germinal centres that produce pathogenic autoantibodies in the thyroid during autoimmune disease.
16. Salomonsson, S. et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 48, 3187-3201 (2003).
17. Manzo, A. et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol. 35, 1347-1359 (2005).
18. Takemura, S. et al. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167, 1072-1080 (2001).
19. MacLennan, I. C. M. Germinal centers. Ann. Rev. Immunol. 12, 117-139 (1994).
20. Park, C. S. & Choi, Y. S. How do follicular dendritic cells interact intimately with B cells in the germinal center? Immunology 114, 2-10 (2005).
21. Corcione, A. et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA 101, 11064-11069 (2004).
22. Moser, B. & Eberl, L. Lymphocyte traffic control by chemokines: follicular B helper T cells. Immunol. Lett. 22, 105-112 (2003).
23. Brandtzaeg, P. & Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 25, 570-577 (2004).
24. von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph node. Nature Rev. Immunol. 3, 867-878 (2003).
25. Fu, Y. & Chaplin, D. D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17, 399-433 (1999).
26. Gommerman, J. L. & Browning, J. L. Lymphotoxin/ LIGHT, lymphoid microenvironments and autoimmune disease. Nature Rev. Immunol. 3, 642-655 (2003).
27. Ware, C. F. Network communications: lymphotoxins, LIGHT and TNF. Annu. Rev. Immunol. 23, 787-819 (2005).
28. Kratz, A., Campos-Neto, A., Hanson, M. S. & Ruddle, N. H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183, 1461-1472 (1996). This paper was the first to show that expression of LTα in a non-lymphoid tissue induces inflammation with lymphoid neogenesis.
29. Cuff C. A. et al. Lymphotoxin α3 induces chemokines and adhesion molecules: insight into the role of LTα in inflammation and lymphoid organ development. J. Immunol. 161, 6853-6860 (1998).
30. Hjelmström, P. et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156, 1133-1138 (2000).
31. Drayton, D. L. et al. Ectopic LTαβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197, 1153-1163 (2003).
32. Schrama, D. et al. Targeting of lymphotoxin-α to the tumour elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 14, 111-121 (2001). This paper shows that delivery of LTα into an experimental tumour leads to the formation of ectopic lymphoid tissue, which sustains an antitumour immune response.
33. Kim, H. -J. et al. Establishment of early lymphoid infrastructure in transplanted tumours mediated by local production of lymphotoxin α in the combined absence of functional B and T cells. J. Immunol. 172, 4037-4047 (2004).
34. Yu, P. et al. Priming of naive T cells inside tumours leads to eradication of established tumours. Nature Immunol. 5, 141-149 (2004).
35. Fan, L., Reilly, C. R., Luo, Y., Dorf, M. E. & Lo, D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164, 3955-3959 (2000).
36. Chen, S. C. et al. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168, 1001-1008 (2000). This study highlights the influence of tissue-specific microenvironments on the induction of lymphoid neogenesis.
37. Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471-481 (2000). This paper shows that ectopically expressed CXCL13 is sufficient to induce lymphoid neogenesis.
38. Luther, S. A. et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169, 424-433 (2002).
39. Martin, A. P. et al. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 173, 4791-4798 (2004).
40. Mazzucchelli, L. et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104, R49-R54 (1999). This paper was the first to show that lymphoid chemokine expression is associated with lymphoid neogenesis in an infectious disease.
41. Shi, K. et al. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J. Immunol. 166, 650-655 (2001).
42. Grant, A. J. et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am. J. Pathol. 160, 1445-1455 (2002).
43. + T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170, 6320-6328 (2003).
44. Aust, G. et al. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur. J. Endocrinol. 150, 225-234 (2004).
45. Page, G. & Miossec, P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204, 28-38 (2004).
46. Serafini, B., Rosicarelli, B., Magliozzi, R. & Aloisi. F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14, 164-174 (2004). This paper was the first to describe fully developed B-cell follicles in the meninges of patients with multiple sclerosis.
47. Faveeuw, C., Gagnerault, M. C. & Lepault, F. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J. Immunol. 152, 5969-5978 (1994).
48. Yoneyama, H. et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 193, 35-49 (2001).
49. Katakai, T., Hara, T., Sugai, M., Gonda, H. & Shimizu, A. Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand-13-producing stromal network in chronic lesions of autoimmune gastritis. J. Immunol. 171, 4359-4368 (2003).
50. Shomer, N. H., Fox, J. G., Juedes, A. E. & Ruddle, N. H. Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue. Infect. Immun. 71, 3572-3577 (2003).
51. Magliozzi, R., Columba-Cabezas, S., Serafini, B. & Aloisi. F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148, 11-23 (2004).
52. Bistrup, A. et al. Detection of a sulfontranserase (HEC-GlcNac6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope. Am. J. Pathol. 164, 1635-1644 (2004).
53. Carlsen, H. S., Baekkevold, E. S., Johansen, F. -E., Haraldsen, G. & Brandtzaeg, P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 51, 364-371 (2002).
54. Carlsen, H. S., Baekkevold, E. S., Morton, H. C., Haraldsen, G. & Brandtzaeg, P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104, 3021-3027 (2004).
55. Amft, N. et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum. 44, 2633-2641 (2001).
56. Grant, A. J., Lalor, P., Hubscher, S. G., Briskin, M. & Adams, D. H. MAdCAM-1 expression is increased in primary sclerosing cholangitis and supports lymphocyte adhesion to hepatic endothelium: a mechanism to explain the recruitment of mucosal lymphocytes to the liver in inflammatory liver disease. Hepatology 33, 1065-1073 (2001).
57. Kobayashi, M. et al. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc. Natl Acad. Sci. USA 101, 17807-17812 (2004).
58. Barone, F. et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum. 52, 1773-1784 (2005).
59. Wyatt, J. I. & Rathbone, B. J. Immune response of the gastric mucosa to Campylobacter pylori. Scand. J. Gastroenterol. Suppl. 142, 44-49 (1988).
60. Schröder, A. E., Greiner, A., Seyfert, C. & Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 93, 221-225 (1996). This study provides the first evidence for antigen-driven B-cell responses in an autoimmune lesion.
61. Sims, G. P., Shiono, H., Willcox, N. & Stott, D. I. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167, 1935-1944 (2001).
62. Camacho, S. A., Kosco-Vilbois, M. H. & Berek, C. The dynamic structure of the germinal center. Immunol. Today 19, 511-514 (1998).
63. Genta, R. M., Hammer, H. W. & Graham, D. Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum. Pathol. 24, 577-583 (1993).
64. Kang, Y. M. et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195, 1325-1336 (2002). This paper highlights the importance of B-cell-T-cell interactions in the induction of ectopic germinal centres.
65. Manser, T. Textbook germinal centers? J. Immunol. 172, 3369-3375 (2004).
66. Cupedo T., Jansen, W., Krall, G. & Mebius, R. E. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 21, 655-667 (2004). This study provides evidence that immune activation is required for complete organization of ectopic lymphoid tissue.
67. Ludewig, B., Odermatt, B., Landmann, S., Hentgartner, H. & Zinkernagel, R. M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188, 1493-1501 (1998).
68. Moyron-Quiroz, J. E. et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nature Med. 10, 927-934 (2004). This study shows that an infectious challenge can induce lymphoid neogenesis in LTα-deficient mice, which lack SLOs.
69. Perrier, P. et al. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172, 7031-7042 (2004).
70. Christopherson, K. W., Hood, A. F., Travers, J. B., Ramsey, H. & Hromas, R. A. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood 101, 801-806 (2003).
71. Weninger, W. et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J. Immunol. 170, 4638-4648 (2003).
72. Chen, S. C. et al. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J. Immunol. 168, 1009-1017 (2000).
73. Burman A. et al. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J. Immunol. 174, 1693-1700 (2005).
74. Carlsen, H. S., Haraldsen, G., Brandtzaeg, P. & Baekkevold, E. S. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 106, 444-446 (2005).
75. Lindhout, E. et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J. Immunol. 162, 5949-5956 (1999).
76. Parsonage, G. et al. A stromal address code defined by fibroblasts. Trends Immunol. 26, 150-156 (2005).
77. Ambrosini, E. et al. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64, 706-715 (2005).
78. Bofill, M. et al. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am. J. Pathol. 119, 462-473 (1985).
79. Roxanis, I., Micklem, K., McConville, J., Newsom-Davis, J. & Willcox, N. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis. J. Neuroimmunol. 125, 185-197 (2002).
80. Randen, I., Mellbye, O. J., Forre, O. & Natvig, J. B. The identification of germinal centers and follicular dendritic cell networks in rheumatoid synovial tissue. Scand. J. Immunol. 41, 481-486 (1995).
81. Aziz, K. E., McCluskey, P. J. & Wakefield, D. Characterization of follicular dendritic cells in labial salivary glands of patients with primary Sjögren's syndrome: comparison with tonsillar lymphoid follicles. Ann. Rheum. Dis. 56, 140-143 (1997).
82. Uccelli, A., Aloisi, F. & Pistoia, V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 26, 254-259 (2005).
83. Campbell, D. A., Poulter, L. W., Janossy, G. & du Bois, R. M. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 40, 405-411 (1985).
84. Wallace, W. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis. J. Pathol. 178, 323-329 (1996).
85. Stott, D. I., Hiepe, F., Hummel, M., Steinhauser, G. & Berek, C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's sindrome. J. Clin. Invest. 102, 938-946 (1998).
86. Kim, H. -J., Krenn, V., Steinhauser, G. & Berek, C. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J. Immunol. 162, 3053-3062 (1999).
87. H genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102, 1045-1050 (1998).
88. Itoh, K et al. Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J. Exp. Med. 192, 1151-1164 (2000).
89. Zhang, Z., Wu, X., Limbaugh, B. H. & Bridges Jr, S. L. Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin κ light chains in rheumatoid arthritis synovial tissue. Arthritis Rheum. 44, 2275-2284 (2001). This study shows that B-cell-receptor revision occurs in an autoimmune lesion, which indicates that there is a risk of generating new autoreactive B cells.
90. Szodoray P., Jellestad, P., Teague, M. & Jonsson, R. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjogren's syndrome. Lab. Invest 83, 357-365 (2003).
91. Ohata, J. et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 174, 864-870 (2005).
92. Krumbholz, M. et al. BAFF is produced by astrocytes and upregulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201, 195-200 (2005).
93. Shiono, H. et al. Failure to downregulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis. Eur. J. Immunol. 27, 805-809 (1997).
94. Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J. & Weyand, C. M. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167, 4710-4718 (2001).
95. Holmoy, T. et al. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur. J. Immunol. 35, 1786-1794 (2005).
96. McMahon, E. J., Bailey, S. L., Vanderlugt Castenada, C., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Med. 11, 335-349 (2005).
97. Stolte, M. & Eidt, S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J. Clin. Pathol. 42, 1269-1271 (1989).
98. Mosnier, J. F. et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 17, 366-371 (1993).
99. Murakami, J. et al. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 30, 143-150 (1999).
100. Sansonno, D. et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur. J. Immunol. 34, 126-136 (2004).
101. Matsumoto, M. et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71, 1301-1309 (1997).
102. Steere, A. C., Duray, P. H. & Butcher, E. C. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Arthritis Rheum. 31, 487-495 (1988).
103. Ghosh, S., Steere, A. C., Stollar, B. D. & Huber, B. T. In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J. Immunol. 174, 2860-2869 (2005).
104. Slavin, R. G. et al. Localization of IgE to lung germinal lymphoid follicles in a patient with allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 90, 1006-1008 (1992).
105. Chvatchko, Y., Kosco-Vilbois, M. H., Herren, S., Lefort, J. & Bonnefoy, J. -Y. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J. Exp. Med. 184, 2353-2360 (1996).
106. Ramshaw, A. L. & Parums, D. V. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 17, 543-552 (1990).
107. Houtkamp, M. A. et al. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J. Pathol. 193, 263-269 (2001).
108. Coronella, J. A. et al. Antigen-driven oligoclonal expansion of tumour-infiltrating B cells in infiltrating ductal carcinoma of the breast. J. Immunol. 169, 1829-1836 (2002).
109. Nzula, S., Going, J. J. & Stott, D. I. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinoma. Cancer Res. 63, 3275-3280 (2003).
110. Baddoura, F. K. et al. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am. J. Transplant. 5, 510-516 (2005).
111. Zinkernagel, R. M. Localization dose and time of antigen determine immune reactivity. Semin. Immunol. 12, 163-171 (2000).
112. Matzinger, P. The danger model: A renewed sense of self. Science 296, 301-305 (2004).
113. Von Herrath, M. G., Fujinami, R. S. & Whitton, J. L. Microorganisms and autoimmunity: making the barren field fertile? Nature Rev. Microbiol. 1, 151-157 (2003).
114. Mattsson, A., Lönroth, H., Quiding-Järbrink, M. & Svennerholm, A. M. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Invest. 102, 51-56 (1998).
115. Buljevac, D. et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125, 952-960 (2002).
116. Wu, Q. et al. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193, 1327-1332 (2001). This paper shows that treatment of NOD mice with an inhibitor of the lymphotoxin pathway reverses insulitis and causes disruption of pancreatic lymphoid aggregates.
117. Zheng, B. et al. CXCL13 neutralization reduces the severity of collagen-induced arthritis. Arthritis Rheum. 52, 620-626 (2005).
118. Gross, J. A. et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 15, 289-302 (2001).
119. Gommerman, J. L. et al. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J. Clin. Invest. 110, 1359-1369 (2002).
120. Monson, N. L. et al. Effect of Rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch. Neurol. 62, 258-264 (2005).
121. Saccardi R. et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 105, 2601-2607 (2005).
122. Vissers, J. L. M., Hartgers, F. C., Lindhout, E., Figdor, C. G. & Adema, G. J. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur. J. Immunol. 31, 1544-1549 (2001).
123. Surawicz, C. M. & Belic L. Rectal biopsy helps to distinguish acute self-limiting colitis from idiopathic inflammatory bowel disease. Gastroenterology 86, 104-113 (1984).
124. Kaiserling, E. Newly formed lymph nodes in the submucosa in chronic inflammatory bowel disease. Lymphology 34, 22-29 (2001).
125. Mooij, P., de Wit, H. J. & Drexhage, H. A. An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin. Immunol. Immunopathol. 69, 189-198 (1993).
126. Oshima, C. et al. Induction of follicular gastritis following postthymectomy autoimmune gastritis in Helicobacter-pylori-infected BALB/c mice. Infect. Immun. 68, 100-106 (2000).